Literature DB >> 15591623

Chemokines: control of primary and memory T-cell traffic.

Patrick Schaerli1, Bernhard Moser.   

Abstract

Motility is a hallmark of leukocytes, and breakdown in the control of migration contributes to many inflammatory diseases. Chemotactic migration of leukocytes largely depends on adhesive interaction with the substratum and recognition of a chemoattractant gradient. Chemokines are secreted proteins and have emerged as key controllers of integrin function and cell locomotion. Numerous distinct chemokines exist that target all types of leukocytes, including hematopoietic precursors, leukocytes of the innate immune system, as well as naive memory, and effector lymphocytes. The combinatorial diversity in responsiveness to chemokines ensures the proper tissue distribution of distinct leukocyte subsets under normal and pathological conditions. Inflammatory chemokines are readily detected in lesional tissue and local cellular infiltrates carry corresponding chemokine receptors. Blocking of inflammatory chemokines represents a promising strategy for the development of novel anti-inflammatory therapeutics. This review focuses on a separate class of chemokines, termed homeostatic chemokines, with steady-state production at diverse sites, including primary and secondary lymphoid tissues as well as peripheral (extralymphoid) tissues. More precisely, we discuss the chemokines involved in T-cell traffic during the initiation of adaptive immunity and compare the distinct migration properties of short-lived effector T cells and long-lived memory T cells. Memory T cells are currently classified according to the presence of the lymph node-homing receptor CCR7 into CCR7+ central memory T (T(CM)) cells and CCR7- effector memory T (T(EM)) cells. For better understanding memory T-cell function, we propose the distinction of a third category, termed peripheral immune surveillance T (T(PS)) cells, which typically reside in healthy peripheral tissues, such as skin, lung, and gastrointestinal tract. Localization and relocation of memory T cells is strictly related to their function in recall responses. Therefore, detailed knowledge of their generation and tissue distribution may help to design better vaccination strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15591623     DOI: 10.1385/IR:31:1:57

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  122 in total

1.  CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses.

Authors:  R Varona; R Villares; L Carramolino; I Goya ; A Zaballos ; J Gutiérrez; M Torres; C Martínez-A; G Márquez
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin.

Authors:  J L Pablos; A Amara; A Bouloc; B Santiago; A Caruz; M Galindo; T Delaunay; J L Virelizier; F Arenzana-Seisdedos
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 3.  Chemokines: multiple levels of leukocyte migration control.

Authors:  Bernhard Moser; Marlene Wolf; Alfred Walz; Pius Loetscher
Journal:  Trends Immunol       Date:  2004-02       Impact factor: 16.687

4.  Cloning and characterization of exodus, a novel beta-chemokine.

Authors:  R Hromas; P W Gray; D Chantry; R Godiska; M Krathwohl; K Fife; G I Bell; J Takeda; S Aronica; M Gordon; S Cooper; H E Broxmeyer; M J Klemsz
Journal:  Blood       Date:  1997-05-01       Impact factor: 22.113

5.  Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation.

Authors:  W W Agace; A Amara; A I Roberts; J L Pablos; S Thelen; M Uguccioni; X Y Li; J Marsal; F Arenzana-Seisdedos; T Delaunay; E C Ebert; B Moser; C M Parker
Journal:  Curr Biol       Date:  2000-03-23       Impact factor: 10.834

6.  The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system.

Authors:  K A Papadakis; J Prehn; V Nelson; L Cheng; S W Binder; P D Ponath; D P Andrew; S R Targan
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

7.  Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC).

Authors:  B Homey; W Wang; H Soto; M E Buchanan; A Wiesenborn; D Catron; A Müller; T K McClanahan; M C Dieu-Nosjean; R Orozco; T Ruzicka; P Lehmann; E Oldham; A Zlotnik
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

8.  Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans.

Authors:  Y Tanaka; T Imai; M Baba; I Ishikawa; M Uehira; H Nomiyama; O Yoshie
Journal:  Eur J Immunol       Date:  1999-02       Impact factor: 5.532

9.  Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues.

Authors:  Daniel J Campbell; Eugene C Butcher
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

10.  Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues.

Authors:  R T Palframan; S Jung; G Cheng; W Weninger; Y Luo; M Dorf; D R Littman; B J Rollins; H Zweerink; A Rot; U H von Andrian
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

View more
  23 in total

Review 1.  Cytokine regulation of B-cell migratory behavior favors formation of germinal centers in autoimmune disease.

Authors:  John D Mountz; John H Wang; Shutao Xie; Hui-Chen Hsu
Journal:  Discov Med       Date:  2011-01       Impact factor: 2.970

2.  Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells.

Authors:  Michael T Hensel; Tao Peng; Anqi Cheng; Stephen C De Rosa; Anna Wald; Kerry J Laing; Lichen Jing; Lichun Dong; Amalia S Magaret; David M Koelle
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

3.  FOXO1 increases CCL20 to promote NF-κB-dependent lymphocyte chemotaxis.

Authors:  Hongming Miao; Yang Zhang; Zhongyan Lu; Liqing Yu; Lixia Gan
Journal:  Mol Endocrinol       Date:  2012-01-12

4.  Apigenin reduces the Toll-like receptor-4-dependent activation of NF-κB by suppressing the Akt, mTOR, JNK, and p38-MAPK.

Authors:  Arum Kim; Chung Soo Lee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-12-20       Impact factor: 3.000

5.  Peripheral and site-specific CD4(+) CD28(null) T cells from rheumatoid arthritis patients show distinct characteristics.

Authors:  J Pieper; S Johansson; O Snir; L Linton; M Rieck; J H Buckner; O Winqvist; R van Vollenhoven; V Malmström
Journal:  Scand J Immunol       Date:  2014-02       Impact factor: 3.487

6.  Apocynin inhibits Toll-like receptor-4-mediated activation of NF-κB by suppressing the Akt and mTOR pathways.

Authors:  Yoon Jeong Nam; Arum Kim; Dong Suep Sohn; Chung Soo Lee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-02       Impact factor: 3.000

7.  Skin- and gut-homing molecules on human circulating γδ T cells and their dysregulation in inflammatory bowel disease.

Authors:  E R Mann; N E McCarthy; S T C Peake; A N Milestone; H O Al-Hassi; D Bernardo; C T Tee; J Landy; M C Pitcher; S A Cochrane; A L Hart; A J Stagg; S C Knight
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

Review 8.  Targeting cells in motion: migrating toward improved therapies.

Authors:  Jason W Griffith; Andrew D Luster
Journal:  Eur J Immunol       Date:  2013-05-13       Impact factor: 5.532

9.  Brefeldin A reduces tumor necrosis factor-α-stimulated production of inflammatory mediators by suppressing the Akt, mTOR, and NF-κB pathways in human keratinocytes.

Authors:  Yoon Jeong Nam; Chung Soo Lee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-20       Impact factor: 3.000

10.  Early development of human hematopoietic and acquired immune systems in new born NOD/Scid/Jak3null mice intrahepatic engrafted with cord blood-derived CD34 + cells.

Authors:  Seiji Okada; Hideki Harada; Takaaki Ito; Takashi Saito; Shinya Suzu
Journal:  Int J Hematol       Date:  2008-11-28       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.